Industry Focus

Healthcare: How Doctors Treat Dementia and Lung Cancer Could Be About to Change

09.11.2019 - By The Motley FoolPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Acadia Pharmaceuticals' dementia-related psychosis trial offers new hope to patients diagnosed with Alzheimer's disease.  Also, results from a lung cancer trial just strengthened Eli Lilly's leadership in precision medicine. Stocks: ACAD, LLY

More episodes from Industry Focus